Loading...
Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation
Atrial fibrillation is the most common cause of stroke. Treatment with anticoagulants in patients with atrial fibrillation reduces embolic complications of the disease including stroke. However, the commonly used anticoagulant has a narrow therapeutic index, requires routine monitoring, and has nume...
Na minha lista:
| Udgivet i: | Ther Adv Cardiovasc Dis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933600/ https://ncbi.nlm.nih.gov/pubmed/26378211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944715605011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|